BONST
AGN

Bank of Nova Scotia Trust’s Allergan plc AGN Stock Holding History

Bank of Nova Scotia Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,003
Closed -$1.23M – 438
2017
Q3 		$1.23M Buy
6,003
+1,503
+33% +$350K 0.13% 72
2017
Q2 		$1.09M Buy
4,500
+2,300
+105% +$540K 0.12% 69
2017
Q1 		$526K Hold
2,200
– – 0.06% 82
2016
Q4 		$462K Sell
2,200
-4
-0.2% -$829 0.05% 84
2016
Q3 		$508K Sell
2,204
-2,500
-53% -$611K 0.06% 81
2016
Q2 		$1.09M Buy
+4,704
New +$1.08M 0.14% 63

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Bank of Nova Scotia Trust's AGN Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 6,003 shares — an estimated $1.23M sold.

Bank of Nova Scotia Trust first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $1.23M in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Bank of Nova Scotia Trust reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 6,003 Allergan plc shares in Q4 2017, an estimated $1.23M.
  • Bank of Nova Scotia Trust first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Bank of Nova Scotia Trust's Allergan plc position peaked at $1.23M in Q3 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.